A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-18
DOI
10.3389/fimmu.2022.927565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics in China and United States, 2022: profiles, trends, and determinants
- (2022) Changfa Xia et al. CHINESE MEDICAL JOURNAL
- A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability
- (2021) Pengpeng Zhu et al. ONCOGENE
- Tenascin-W: Discovery, Evolution, and Future Prospects
- (2021) Martin Degen et al. Frontiers in Immunology
- Stromal Score-Based Gene Signature: A Prognostic Prediction Model for Colon Cancer
- (2021) Jing Jia et al. Frontiers in Genetics
- A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma
- (2021) Qianli Ma et al. Translational Lung Cancer Research
- A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma
- (2021) Jie Wu et al. ONCOGENE
- The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities
- (2021) Umar Mehraj et al. CELLULAR ONCOLOGY
- The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
- (2021) Kai Li et al. Scientific Reports
- Establishment of a Prognostic Signature of Stromal/Immune-Related Genes for Gastric Adenocarcinoma Based on ESTIMATE Algorithm
- (2021) Shan Yu et al. Frontiers in Cell and Developmental Biology
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies
- (2020) Sayda Dhaouadi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer
- (2020) Guang-jie Liu et al. Scientific Reports
- Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer
- (2020) Shiyuan Wang et al. BRIEFINGS IN BIOINFORMATICS
- FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis
- (2020) Ying Song et al. ONCOGENE
- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
- (2019) Yi-Zhou Jiang et al. CANCER CELL
- Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T Cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms
- (2019) Cansu Cimen Bozkus et al. Cancer Discovery
- Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment
- (2019) Wen-Hao Xu et al. Aging-US
- Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer
- (2019) Li Liu et al. CLINICAL CANCER RESEARCH
- Cancer and the Immune System: The History and Background of Immunotherapy
- (2019) Maura Abbott et al. Seminars in Oncology Nursing
- VISTA is an acidic pH-selective ligand for PSGL-1
- (2019) Robert J. Johnston et al. NATURE
- Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
- (2019) Hao Wang et al. Frontiers in Oncology
- Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway
- (2018) Lui Ng et al. BMC CANCER
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy: broadening the scope of targetable tumours
- (2018) Jitske van den Bulk et al. Open Biology
- miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR
- (2018) Lansheng Zhang et al. OncoTargets and Therapy
- Non-coding Class Switch Recombination-Related Transcription in Human Normal and Pathological Immune Responses
- (2018) Helena Kuri-Magaña et al. Frontiers in Immunology
- Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways
- (2017) Amir Tajbakhsh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
- (2017) Maria Vittoria Dieci et al. SEMINARS IN CANCER BIOLOGY
- Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
- (2017) Oakley C. Olson et al. Cell Reports
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy
- (2017) Yi-Ying Lee et al. Journal of Cancer
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
- (2016) Marco De Simone et al. IMMUNITY
- Specific expression and methylation of SLIT1, SLIT2, SLIT3, and miR-218 in gastric cancer subtypes
- (2016) MIRANG KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Translational Implications of Tumor Heterogeneity
- (2015) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
- (2015) Kamolporn Amornsupak et al. BMC CANCER
- Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
- (2014) Armel Herve Nwabo Kamdje et al. CELLULAR SIGNALLING
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Down-Regulation of miR-218-2 and Its Host Gene SLIT3 Cooperate to Promote Invasion and Progression of Thyroid Cancer
- (2013) Hongyu Guan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Expression and roles of Slit/Robo in human ovarian cancer
- (2011) Cai Feng Dai et al. HISTOCHEMISTRY AND CELL BIOLOGY
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started